BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(221 sites)

United States

Mayo Clinic Hospital in Arizona, Phoenix, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Tower Cancer Research Foundation, Beverly Hills, California

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California

The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California

Rocky Mountain Regional VA Medical Center, Aurora, Colorado

UCHealth Memorial Hospital Central, Colorado Springs, Colorado

Memorial Hospital North, Colorado Springs, Colorado

Poudre Valley Hospital, Fort Collins, Colorado

Cancer Care and Hematology-Fort Collins, Fort Collins, Colorado

UCHealth Greeley Hospital, Greeley, Colorado